Lucas Manoel da Silva Sousa

Lucas Manoel da Silva Sousa

Auto-generated profile, based on publicly available information

Lucas Manoel da Silva Sousa

Federal University of Pernambuco Avenida Artur de Sá S/N

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

24 September 2026 in ACS Omega
Verified
Journal Article
Open access
IDIngrid de Oliveira Dias
Ingrid de Oliveira Dias
GMGabriel CânDido Moura
Gabriel CânDido Moura
LSLucas Manoel da Silva Sousa
Lucas Manoel da Silva Sousa
RMRafael Meyer Mariante
Rafael Meyer Mariante
ALAna Cristina Leite
Ana Cristina Leite
Juliana ReimãoJuliana Reimão
Juliana Reimão
Toxoplasmosis, caused by the protozoan Toxoplasma gondii, remains a significant global health challenge, particularly for immunocompromised individuals. Current therapies, based on pyrimethamine and sulfadiazine, are limited by toxicity, suboptimal efficacy, and the emergence of resistant parasite strains, highlighting the need for safer and more effective alternatives. In this study, we evaluated the antiparasitic potential of six 2-pyridyl 1,3-thiazole derivatives─privileged scaffolds previously reported for potent antitumor activity but never investigated against T. gondii. In vitro assays were performed using intracellular tachyzoites of the RH strain and human foreskin fibroblasts to determine antiparasitic activity and host-cell cytotoxicity. The derivatives exhibited half-maximal effective concentrations (EC50) between 212 and 490 nM and cytotoxicity values (CC50) ranging from 1.5 to 48 μM. One compound, TAP-05, demonstrated a notable selectivity index of 183.26, exceeding that of the reference drug pyrimethamine, supporting its potential as a lead candidate for further optimization. Transmission electron microscopy of treated parasites revealed reduced ultrastructural signs of tachyzoite division and increased cytoplasmic vacuolization compared to untreated controls, along with occasional Golgi perturbations. These qualitative observations raise the hypothesis of a cytostatic effect of TAP-05 on parasite replication, which requires confirmation by dedicated functional assays. These findings identify a promising thiazole-based chemotype for toxoplasmosis drug discovery and warrant additional studies to elucidate mechanisms of action and assess in vivo efficacy.